IBRX•benzinga•
HC Wainwright & Co. Initiates Coverage On ImmunityBio with Buy Rating, Announces Price Target of $8
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 6, 2025 by benzinga